Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB registry-Reference-Cited by-同舟云学术

Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two‐year results from the German‐Austrian ABSORB registry

Published:2021-06-17 Issue: Volume: Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Tröbs Monique¹^ORCID,Achenbach Stephan¹^ORCID,Nef Holger M.²,Gori Tomasso³,Naber Christoph⁴,Neumann Till⁵,Richardt Gert⁶,Schmermund Axel⁷,Wöhrle Jochen⁸,Zahn Ralf⁹,Hamm Christian W.²¹⁰,

Affiliation:

1. Friedrich‐Alexander Universität Erlangen‐Nürnberg Department of Cardiology Erlangen Germany

2. Medizinische Klinik I, Department of Cardiology University of Giessen Giessen Germany

3. Department of Medicine II University Medical Center, Johannes Gutenberg University Mainz Mainz Germany

4. Medizinische Klinik 1 Klinikum Wilhelmshaven Wilhelmshaven Germany

5. Department of Cardiology University of Essen Essen Germany

6. Herzzentrum Segeberger Kliniken GmbH Bad Segeberg Germany

7. CCB Cardioangiologisches Centrum Bethanien Hospital Frankfurt Germany

8. Department of Cardiology Medical Campus Lake Constance Friedrichshafen Germany

9. Abteilung für Kardiologie Herzzentrum Ludwigshafen Ludwigshafen Germany

10. Department of Cardiology Kerckhoff Heart and Thorax Center Bad Nauheim Germany

Funder

Abbott Vascular

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.29831

Reference23 articles.

1. Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

2. Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents

3. Bioresorbable Scaffolds versus Metallic Stents in Routine PCI

4. From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?

5. Bioresorbable Vascular Scaffold During ST-Elevation Myocardial Infarction: A Systematic Review

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Adverse Prognosis in Patients With Acute Coronary Syndrome Caused by Plaque Erosion With a Nonstent Strategy;Journal of the American Heart Association;2022-12-20